Jul 12, 2007 7:30am EDT Rigel Announces Start of Phase 1 Combination Therapy Study of R763/AS703569 in Advanced Malignancies
Apr 11, 2007 7:30am EDT Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
Mar 14, 2007 7:30am EDT Rigel Announces Presentation at the Lehman Brothers Global Healthcare Conference
Feb 13, 2007 7:30am EST Rigel Announces Initiation of Phase 1 Study Evaluating R763 in Hematological Malignancies
